By 
The World Health Organization (WHO) and the United States Agency for International Development (USAID) have donated a batch of molecular biology test kits for Mpox to Angola’s National Institute for Health Research (INIS). This collaboration aims to enhance Angola’s capacity to swiftly detect and respond to Mpox cases, marking an important step in supporting the country’s public health system as it confronts the recent emergence of the disease.
The donation was received by Dr Joana Paula da Paixão, Deputy Director of INIS. Speaking at the handover ceremony, Dr Paixão stated: “This support from WHO and USAID is important for Angola. With these kits, we can boost our capacity to detect Mpox cases and respond quickly. This contribution complements ongoing efforts to ensure our public health systems are equipped to safeguard Angolans.”
The donated kits include Cepheid GeneXpert cartridges, which provide faster results—delivering outcomes within just one hour compared to the four hours required by traditional RT-PCR tests. This adaptability enables the technology to be used to enhance diagnostic capacity across various regions of the country. The donation builds on previous contributions from WHO and USAID, which together have provided Angola with over 150 test kits.
The ongoing collaboration between international partners underscores the global commitment to strengthening Angola’s healthcare system. In addition to USAID and WHO, the United States Centers for Disease Control and Prevention (CDC) and other partners are also supplying diagnostic kits and technical support to bolster Angola’s response to the Mpox outbreak.
With these resources, Angola is better equipped to detect cases and contain the spread of Mpox. WHO and its partners remain committed to supporting Angola’s health system, ensuring the country has the tools necessary to protect its population.
Comments